Hillard Lyons raises its rating on Tempur-Pedic TPX from Long-Term Buy to Buy and reduces its price target from $70 to $35.
Hillard Lyons says, "The shares are currently trading at discounts to five-year median multiples averaging ~50% vs. current and forward forecasts. As such, we are increasing our rating on TPX to Buy with a 12-month target price of $35. That compares to our previous Long-term Buy rating with a 24-month price target of $70. Our revised target values the shares at 10.3x FY'13E earnings and 5.4x EV / FY'13E EBITDA, a ~40% average discount to the historical median multiples which we believe is compelling given the company's free cash flow margin potential and free cash flow yield following the sell-off."
TPX closed at $22.39 on Thursday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in